Allianz Asset Management Gmb H Summit Therapeutics Inc. Transaction History
Allianz Asset Management Gmb H
- $74.9 Billion
- Q2 2025
A detailed history of Allianz Asset Management Gmb H transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 29,800 shares of SMMT stock, worth $651,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,800
Previous 42,861
30.47%
Holding current value
$651,428
Previous $826,000
23.24%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SMMT
# of Institutions
266Shares Held
90.9MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$737 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$190 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$173 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$87.8 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$85.4 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.4B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...